Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat Patients with Tinnitus (US)(?)

Council Members in this Study Group: 23

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Interesting, but be careful with the interpretation | 05-13-2008
Author: GLG Expert Contributor

There are interesting findings presented from the phase 3 study.  However, great care should be used in the analysis as it is fairly easy to spin this in a positive direction which may not correlate with a patient's symptomatic improvement.

An issue of prescription coverage | 03-05-2008
Author: GLG Expert Contributor

The approval of the pediatric indication for nexium gives a useful alternative to Prevacid.  However, this is already a crowded field where managed care often dictates which PPI is used.  This will likely steal some market share from Prevacid, but will probably be a small addition to Nexium's...

Different Spin On Same Story | 12-07-2007
Author: GLG Expert Contributor

This article highlights the problems facing studies looking at the treatment of acute sinusitis.  Many in big pharma tout excellent efficacy rates for their products treating uncomplicated acute bacterial sinusitis.  In reality, the vast majority of these patients would improve with conservative...

The Prevelence of Hearing Impairment in the Middle East | 11-08-2007
Analysis of: Health-Care Building Booms in Persian Gulf | online.wsj.com
Author: GLG Expert Contributor

There is a cultural intermarriage component of middle eastern life that increases the prevelence of severe to profound hearing impairment in this region.  At a time when the western world is reducing its hearing impaired population, the middle east is at an all time high for hearing loss as a direct...

The European Veramyst - but ocular symptom control raises questions | 10-29-2007
Author: GLG Expert Contributor

This is the European equivalent of Veramyst.  The control of ocular symptoms is a major marketing push but raises a few questions.  There are concerns regarding cataract formation with the higher potency steroid molecules.  Although low bioavailability is shown, there must be some direct...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Consultancy, Healthcare-Focused
  • Academic Institution*

Most Common Job Types:

  • Physician - Attending Physician
  • Allied Health Professional
  • Owner
  • Physician - Director
  • Audiologist
  • President
  • Consultant
  • Professor
  • Chief Executive Officer
  • Physician - Department Chair
  • Partner

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-08-28T05:45:17.053